First treatment approved for disease linked to stem cell transplant
(HealthDay)—Defitelio (defibrotide sodium) has been approved by the U.S. Food and Drug Administration to treat a rare, but usually fatal liver disease that affects some people who have had a stem cell transplant.
Mar 30, 2016
0
3